0001415889-22-006747.txt : 20220617 0001415889-22-006747.hdr.sgml : 20220617 20220617163118 ACCESSION NUMBER: 0001415889-22-006747 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220615 FILED AS OF DATE: 20220617 DATE AS OF CHANGE: 20220617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Huber Martin H. Jr. CENTRAL INDEX KEY: 0001653276 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 221024343 MAIL ADDRESS: STREET 1: C/O TESARO, INC. STREET 2: 1000 WINTER STREET, SUITE 3300 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xilio Therapeutics, Inc. CENTRAL INDEX KEY: 0001840233 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851623397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-833-1027 MAIL ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-06172022_040644.xml X0306 4 2022-06-15 0001840233 Xilio Therapeutics, Inc. XLO 0001653276 Huber Martin H. Jr. 828 WINTER STREET SUITE 300 WALTHAM MA 02451 false true false false PRESIDENT AND HEAD OF R&D Stock Option (right to buy) 2.28 2022-06-15 4 A 0 20000 0 A 2032-06-14 Common Stock 20000 20000 D The option award was granted on June 15, 2022 and will vest in equal monthly installments until June 15, 2026, subject to the Reporting Person's continued service through the applicable vesting date. /s/ Chris Frankenfield, Attorney-in-Fact 2022-06-17